BKYI.OQBBio Key International INC
DEF 14A: BIO-key International Sets Date for 2024 Annual Stockholders Meeting
Sentiment:
Proxy Statement
BIO-key International will hold its 2024 Annual Meeting of Stockholders on August 22, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.
Summary
- BIO-key International, Inc. will hold its 2024 Annual Meeting of Stockholders on August 22, 2024, at its Holmdel, NJ offices.
- Stockholders of record as of July 1, 2024, are eligible to vote on the election of five directors, ratification of the selection of Bush & Associates CPA LLC as the independent auditor, an advisory vote on executive compensation, and an advisory vote on the frequency of executive compensation approval.
- The board of directors recommends voting for the election of the nominated directors, for the ratification of Bush & Associates CPA LLC, for the approval of executive compensation, and for holding advisory votes on executive compensation every year.
- The proxy statement provides information on corporate governance, executive and director compensation, related party transactions, and other matters relevant to the meeting.
- As of July 1, 2024, there were 1,814,228 shares of common stock outstanding.
Sentiment
Score: 7
Explanation: The document is neutral in tone, providing factual information about the upcoming annual meeting and related proposals. While there are mentions of net losses, the overall sentiment is stable as it focuses on governance and compliance.
Positives
- The company is providing stockholders with the opportunity to vote on important corporate governance matters.
- The board is recommending actions that they believe are in the best interest of stockholders.
- The company is transparently disclosing information about executive compensation and related party transactions.
Negatives
- The company experienced net losses in 2021, 2022 and 2023.
- Performance-based bonuses were not achieved in 2022 or 2023.
- The amount of compensation actually paid to our Non-PEOs was not aligned with our net loss over the three years presented in the table.
Risks
- Failure to achieve sufficient votes in favor of the proposals may require adjournment of the Annual Meeting.
- The advisory vote on executive compensation is non-binding, so the board may choose to disregard the outcome.
- Changes in control could trigger accelerated vesting of equity awards, potentially impacting the company's financial position.
- The company's future performance is subject to various risks, including market conditions and competition.
Future Outlook
The board of directors is seeking stockholder approval on several key proposals to guide the company's direction and governance in the coming year.
Management Comments
- Michael W. DePasquale, Chairman and Chief Executive Officer, invites stockholders to attend the Annual Meeting and encourages them to exercise their right to vote.
- The board of directors and management look forward to seeing stockholders at the meeting and thank them for their continued support.
Industry Context
This proxy statement is a standard document for publicly traded companies, providing stockholders with the information necessary to make informed decisions on important corporate matters.
Comparison to Industry Standards
- The director independence standards used by BIO-key are consistent with NASDAQ Marketplace Rules.
- The company's executive compensation program includes base salary, performance-based bonuses, and long-term equity awards, which is a common practice in the industry.
- The company's audit committee composition and responsibilities align with SEC regulations and best practices.
- The company's process for stockholder communications is in line with industry standards for corporate governance.
Related Party Transactions
- Michael W. DePasquale, James D. Sullivan, and Mr. Sullivans spouse each participated in the public offering on October 31, 2023.
Stakeholder Impact
- The outcome of the votes at the Annual Meeting will impact the composition of the board of directors and the company's corporate governance practices.
- Executive compensation decisions will affect the motivation and retention of key executives.
- The selection of the independent auditor will impact the credibility of the company's financial statements.
- The company's performance and governance practices will ultimately affect shareholder value.
Next Steps
- Stockholders should review the proxy statement and vote on the proposals.
- The company will hold the Annual Meeting on August 22, 2024.
- The board of directors will consider the outcome of the advisory votes on executive compensation and frequency of approval when making future compensation decisions.
- The audit committee will continue to oversee the company's financial reporting and the performance of the independent auditor.
Key Dates
| Date | Description |
|---|---|
| 2015-10-29 | Date of securities purchase agreement with Wong Kwok Fong (Kelvin) |
| 2015-11-11 | Date of securities purchase agreement with Wong Kwok Fong (Kelvin) |
| 2015-12-04 | Wong Kwok Fong (Kelvin) has served as a Director of the Company since this date |
| 2016-08 | Wong Kwok Fong (Kelvin) has served as Managing Director of our Hong Kong Subsidiary since this date |
| 2017-04-05 | We entered into an employment agreement with James Sullivan. |
| 2017-04-10 | Robert J. Michel has served as a Director of the Company since this date. |
| 2018 | Mr. Alia has been providing management consulting services as an advisor to businesses seeking market entry strategies to emerging markets such as Africa and the Caribbean since this date. |
| 2019-03 | Wong Kwok Fong (Kelvin) has served as Vice-Chairman of the Board of Directors since this date |
| 2020-02 | James D. Sullivan has served as BIO-keys Senior Vice President of Strategy and Compliance and Chief Legal Officer since this date |
| 2020-04-03 | Emmanuel Alia (Manny), was appointed Director of the Company on this date. |
| 2023-06-02 | Cameron E. Williams, was appointed Director of the Company on this date. |
| 2023-07-01 | Date for information with respect to the securities holdings of all persons that we, pursuant to filings with the SEC and our stock transfer records, have reason to believe may be deemed the beneficial owner of more than 5% of our common stock. |
| 2023-10-31 | We completed a public offering of shares of common stock and warrants resulting in net proceeds of approximately $3.3 million |
| 2024-04-23 | Our audit committee dismissed Marcum LLP (Marcum) as the Companys independent registered public accounting firm |
| 2024-04-24 | Our audit committee approved the engagement of Bush as the Companys independent registered public accounting firm. |
| 2024-07-01 | Record date for stockholders eligible to vote at the Annual Meeting. |
| 2024-07-10 | Date of the letter to stockholders and the Notice of Annual Meeting of Stockholders. |
| 2024-07-12 | Beginning on or about this date, we mailed to our stockholders our Annual Report on Form 10-K for the year ended December 31, 2023, together with these proxy materials. |
| 2024-08-12 | A list of stockholders entitled to vote at the Annual Meeting will be available for inspection at the Annual Meeting and at our corporate offices beginning on this date. |
| 2024-08-21 | Internet and telephone voting facilities will close at 11:59 p.m. ET on this date. |
| 2024-08-22 | Date of the 2024 Annual Meeting of Stockholders. |
| 2025 | The elected directors will serve until the 2025 Annual Meeting of Stockholders. |
| 2025-03-12 | Deadline for stockholders to submit proposals for inclusion in the 2025 Annual Meeting proxy statement. |
| 2025-05-24 | Stockholders wishing to present proposals for action at an annual meeting apart from proposals pursuant to Rule 14a-8 must do so in accordance with our bylaws. Such proposals must be submitted in writing at the address shown above, so that it is received between this date and June 23, 2025. |
| 2025-06-23 | Stockholders wishing to present proposals for action at an annual meeting apart from proposals pursuant to Rule 14a-8 must do so in accordance with our bylaws. Such proposals must be submitted in writing at the address shown above, so that it is received between May 24, 2025 and this date. |
| 2025-06-23 | In addition, if applicable, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Companys nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than this date. |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Executive Compensation, Board of Directors, Director Election, Auditor Ratification, Corporate Governance, BIO-key International
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.